1,4-bis(4-nitrophenethyl)piperazine

ID: ALA2146755

Chembl Id: CHEMBL2146755

PubChem CID: 52337837

Max Phase: Preclinical

Molecular Formula: C20H24N4O4

Molecular Weight: 384.44

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: 1,4-Bis(4-Nitrophenethyl)Piperazine | CHEMBL2146755|SCHEMBL2731306|GKZBQPSXHBJOPU-UHFFFAOYSA-N|BDBM50391770|1,4-Bis(4-Nitrophenethyl)Piperazine|1,4-bis[2-(4-nitrophenyl)ethyl]piperazine

Canonical SMILES:  O=[N+]([O-])c1ccc(CCN2CCN(CCc3ccc([N+](=O)[O-])cc3)CC2)cc1

Standard InChI:  InChI=1S/C20H24N4O4/c25-23(26)19-5-1-17(2-6-19)9-11-21-13-15-22(16-14-21)12-10-18-3-7-20(8-4-18)24(27)28/h1-8H,9-16H2

Standard InChI Key:  GKZBQPSXHBJOPU-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

KCNJ1 Tchem ATP-sensitive inward rectifier potassium channel 1 (862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNJ2 Tchem Inward rectifier potassium channel 2 (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNJ4 Tchem Inward rectifier potassium channel 4 (7 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNJ10 Tbio ATP-sensitive inward rectifier potassium channel 10 (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNJ13 Tchem Inward rectifier potassium channel 13 (9 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 384.44Molecular Weight (Monoisotopic): 384.1798AlogP: 2.91#Rotatable Bonds: 8
Polar Surface Area: 92.76Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.76CX LogP: 3.94CX LogD: 3.43
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.51Np Likeness Score: -0.82

References

1. Tang H, Walsh SP, Yan Y, de Jesus RK, Shahripour A, Teumelsan N, Zhu Y, Ha S, Owens KA, Thomas-Fowlkes BS, Felix JP, Liu J, Kohler M, Priest BT, Bailey T, Brochu R, Alonso-Galicia M, Kaczorowski GJ, Roy S, Yang L, Mills SG, Garcia ML, Pasternak A..  (2012)  Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics.,  (5): [PMID:24900480] [10.1021/ml3000066]
2.  (2015)  Inhibitors of the renal outer medullary potassium channel, 
3. Tang H, Zhu Y, Teumelsan N, Walsh SP, Shahripour A, Priest BT, Swensen AM, Felix JP, Brochu RM, Bailey T, Thomas-Fowlkes B, Pai LY, Hampton C, Corona A, Hernandez M, Metzger J, Forrest M, Zhou X, Owens K, Tong V, Parmee E, Roy S, Kaczorowski GJ, Yang L, Alonso-Galicia M, Garcia ML, Pasternak A..  (2016)  Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure.,  (7): [PMID:27437080] [10.1021/acsmedchemlett.6b00122]